首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   262452篇
  免费   77134篇
  国内免费   2703篇
耳鼻咽喉   6170篇
儿科学   9489篇
妇产科学   4486篇
基础医学   22125篇
口腔科学   10475篇
临床医学   51425篇
内科学   73075篇
皮肤病学   15007篇
神经病学   28511篇
特种医学   9796篇
外科学   57391篇
综合类   335篇
现状与发展   79篇
一般理论   26篇
预防医学   19144篇
眼科学   5769篇
药学   8342篇
中国医学   1242篇
肿瘤学   19402篇
  2024年   723篇
  2023年   6715篇
  2022年   1669篇
  2021年   5517篇
  2020年   12602篇
  2019年   13657篇
  2018年   17747篇
  2017年   19321篇
  2016年   20966篇
  2015年   21407篇
  2014年   28844篇
  2013年   31326篇
  2012年   11431篇
  2011年   11528篇
  2010年   20448篇
  2009年   21412篇
  2008年   9460篇
  2007年   6567篇
  2006年   9224篇
  2005年   5946篇
  2004年   4779篇
  2003年   3585篇
  2002年   3663篇
  2001年   5489篇
  2000年   4360篇
  1999年   4314篇
  1998年   4547篇
  1997年   4320篇
  1996年   4290篇
  1995年   3938篇
  1994年   2553篇
  1993年   2092篇
  1992年   1839篇
  1991年   1784篇
  1990年   1415篇
  1989年   1487篇
  1988年   1321篇
  1987年   1093篇
  1986年   1109篇
  1985年   917篇
  1984年   724篇
  1983年   721篇
  1982年   641篇
  1981年   529篇
  1980年   427篇
  1979年   363篇
  1978年   407篇
  1977年   467篇
  1975年   323篇
  1972年   347篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.

Objective

The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.

Data Source

2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.

Study Design

An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.

Data Collection/Extraction Methods

Not applicable.

Principal Findings

Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.

Conclusion

State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation.  相似文献   
2.
3.
4.
5.
6.
7.
8.
9.
10.
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号